Look for:

Our offer for

VALNEVA SE


ISIN:
FR0004056851
WKN:
-

2022/05/27 17:35:17
Price
11.415 EUR
Difference 3.16% (0.35)

General attributes

ISINFR0004056851
SymbolVLA
ExchangeEuronext Paris
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)1,229 EUR
BenchmarkCAC 40 INDEX

Market data

Bid (Bid size)11.315 EUR (200)
Ask (Ask size)11.50 EUR (200)
Open11.165 EUR
High11.65 EUR
Low11.075 EUR
Close (prev. day)11.065 EUR
VWAP11.388524 EUR
Volume (pcs)463,416
Trading volume5,277,624.00
Number of trades1,818
Last size1,278

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Annual report: VALNEVA SEPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/05/27 17:35:17
Price
11.415 EUR
Difference 3.16% (0.35)

General attributes

ISINFR0004056851
SymbolVLA
ExchangeEuronext Paris
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)1,229 EUR
BenchmarkCAC 40 INDEX

Market data

Bid (Bid size)11.315 EUR (200)
Ask (Ask size)11.50 EUR (200)
Open11.165 EUR
High11.65 EUR
Low11.075 EUR
Close (prev. day)11.065 EUR
VWAP11.388524 EUR
Volume (pcs)463,416
Trading volume5,277,624.00
Number of trades1,818
Last size1,278

Performance and Risk

6M1Y3Y
Perf (%)-56.10%+12.46%+238.72%
Perf (abs.)-14.59+1.27+8.05
Beta1.200.880.47
Volatility96.52109.1580.57
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)11.083 EUR (445,731)
Ø price 30 days | Ø volume 30 days (pcs.)12.328 EUR (874,166)
Ø price 100 days | Ø volume 100 days (pcs.)14.604 EUR (919,578)
Ø price 250 days | Ø volume 250 days (pcs.)15.731 EUR (1,351,314)
YTD High | date24.140 EUR (2022/01/03)
YTD Low | date9.162 EUR (2022/05/16)
52 Weeks High | date29.700 EUR (2021/11/30)
52 Weeks Low | date9.162 EUR (2022/05/16)

All listings for VALNEVA SE

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/05/2717:3511.51 EUR0.1873
Vienna Stock Exchange2022/05/2717:3211.395 EUR0.005
Tradegate2022/05/2722:2611.24 EUR1.06238
Stuttgart2022/05/2721:5711.34 EUR0.0114
Munich2022/05/2720:1111.305 EUR0.013
London Stock Exchange2022/05/1117:0711.8167 EUR0.181
Hanover2022/05/2708:0710.96 EUR0.001
Hamburg2022/05/2708:0710.96 EUR0.001
Frankfurt2022/05/2720:1811.61 EUR0.0413
FINRA other OTC Issues2022/05/2720:2312.34 USD0.058
Euronext Paris2022/05/2717:3511.415 EUR5.281,818
Duesseldorf2022/05/2719:3011.385 EUR0.0114
Berlin2022/05/2708:1110.96 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=137743&ID_TYPE_IMAGE_LOGO=2

Contact Details

VALNEVA SE
- -
Campus Bio-Ouest - 44800 Saint-Herblain
Telefon: 33-2-28-07-37-10
Fax: -
E-mail: info@valneva.com

PDF Downloads

Annual report: VALNEVA SEPDF Download

Company Profile

Valneva SE is a specialty vaccine company. The firm focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. It takes a highly specialized and targeted approach to vaccine development and then applies its deep understanding of vaccine science to develop prophylactic vaccines addressing these diseases. It operates through the following segments: Commercialized products, COVID, Vaccine candidates and Technologies and services. The Commercialized products segment markets vaccines, currently IXIARO and DUKORAL vaccines, as well as third-party products. The COVID segment engages in the development, manufacturing and distribution related to COVID-19 vaccine candidate, VLA2001. The Vaccine candidates segment engages in proprietary research and development programs aiming to generate new approvable products in order to generate future cash flows from product sales or from commercialization through partnering with pharmaceutical companies, excluding COVID-19 vaccine candidate, VLA2001. The Technologies and services segment provides services and inventions at a commercialization stage. The company was founded on April 7, 1999 and is headquartered in Saint-Herblain, France.

Members of Management Board

Thomas LingelbachChairman of Managing Board
Franck GrimaudMember of Executive Committee
Frédéric JacototMember of Executive Committee
Juan Carlos JaramilloMember of Executive Committee
Reinhard KanderaMember of Executive Committee

Board of directors

Frédéric GrimaudChairman of Supervisory Board
Johanna PattenierMember of Supervisory Board
Anne-Marie GraffinMember of Supervisory Board
James SulatMember of Supervisory Board
Peter BuhlerMember of Supervisory Board
Sharon TetlowMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.